方法：回顾性临床分析研究。收集2016-10/2020-01于北京同仁医院眼科就诊的合并视网膜下增生的RRD患者54例54眼，其中男36眼，女18眼，平均年龄24.92±11.99岁，视网膜脱离范围<1、1～2、>2个象限分别为12、25、17眼； 累及黄斑47眼； 视网膜下增生范围<1、1～2、>2个象限分别为26、23、5眼； 术前平均最佳矫正视力(LogMAR)为1.21±0.77； 所有患者均采用全身麻醉下SB，观察术后视网膜复位率、最佳矫正视力及并发症。

结果：术后视网膜复位52眼(96%)，视网膜未复位2眼(4%)，再行玻璃体手术后复位。平均随访时间为19.17±11.15mo，末次随访平均最佳矫正视力(LogMAR)0.61±0.40，手术前后最佳矫正视力比较有差异(P<0.01)。所有患者术中及术后均未发生严重的并发症。

结论：在正确适应证选择的前提下，SB治疗合并视网膜下增生的RRD有较好的成功率。

METHODS: This was a retrospective clinical analysis research. Patients with RRD associated with subretinal proliferation who visited the Beijing Tongren Hospital were included in this study. From October 2016 to January 2020. There were 54 patients, including 36 males and 18 females, with the average age of 24.92±11.99 years. The retinal detachment range <1, 1-2 and >2 quadrants were 12, 25 and 17 eyes, respectively. The macula was involved in 47 eyes. Subretinal proliferation range <1, 1-2 and >2 quadrants were 26, 23 and 5 eyes, respectively. The average Logarithm of the minimum angle of resolution(LogMAR)best corrected visual acuity(BCVA)was 1.21±0.77, all patients were treated with SB under general anesthesia and the anatomical retinal reattachment, visual acuity and complications were observed.

RESULTS: The retina was reattached in 52 eyes(96%), and 2 eyes(4%)needed pars plana vitrectomy for retinal redetachment. The mean follow wp was 19.17±11.15mo. The BCVA improved from 1.21±0.77 LogMAR before surgery to 0.61±0.40 LogMAR after surgery(P<0.01). No serious complications occurred.

CONCLUSION: Under the circumstance of correct selection of indications, SB was highly successful in eyes with RRD associated with subretinal proliferation.